These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 6397517)

  • 1. Effects of the renin inhibitor H77 on the pressor responses to injected pig, rat and dog renins in vivo.
    Oldham AA; Arnstein MJ; Major JS; Clough DP
    J Hypertens; 1983 Aug; 1(2):191-5. PubMed ID: 6397517
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo comparison of the renin inhibitor H77 with the angiotensin-converting enzyme inhibitor captopril.
    Oldham AA; Arnstein MJ; Major JS; Clough DP
    J Cardiovasc Pharmacol; 1984; 6(4):672-7. PubMed ID: 6206324
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of a potent inhibitor of subprimate and primate renins.
    Wood JM; Mah SC; Baum HP; de Gasparo M; Cumin F; Rüeger H; Nussberger J
    J Pharmacol Exp Ther; 1990 May; 253(2):513-7. PubMed ID: 2110974
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Statine-containing renin inhibitor. Dissociation of blood pressure lowering and renin inhibition in sodium-deficient dogs.
    Blaine EH; Schorn TW; Boger J
    Hypertension; 1984; 6(2 Pt 2):I111-8. PubMed ID: 6373590
    [TBL] [Abstract][Full Text] [Related]  

  • 5. H-77: a potent new renin inhibitor. In vitro and in vivo studies.
    Szelke M; Leckie BJ; Tree M; Brown A; Grant J; Hallett A; Hughes M; Jones DM; Lever AF
    Hypertension; 1982; 4(3 Pt 2):59-69. PubMed ID: 7040240
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Non-specific inhibition of pressor agents in vivo by the renin inhibitor pepstatin A.
    Oldham AA; Arnstein MJ; Major JS; Clough DP
    J Hypertens; 1984 Apr; 2(2):157-61. PubMed ID: 6398334
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of the renin inhibitor H77 on angiotensin II, arterial pressure and cardiac function in conscious dogs: comparison with captopril.
    Tree M; MacArthur K; Inglis G; Leckie B; Lever AF; Morton JJ; Szelke M
    J Hypertens Suppl; 1989 Apr; 7(2):S51-5. PubMed ID: 2666615
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CGP 38 560: orally active, low-molecular-weight renin inhibitor with high potency and specificity.
    Wood JM; Criscione L; de Gasparo M; Bühlmayer P; Rüeger H; Stanton JL; Jupp RA; Kay J
    J Cardiovasc Pharmacol; 1989 Aug; 14(2):221-6. PubMed ID: 2476594
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of dog renin activity by pepstatin A.
    Miyazaki M; Komori T; Okunishi H; Toda N
    Jpn Circ J; 1979 Sep; 43(9):818-23. PubMed ID: 501901
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro inhibition of human renin by statine-containing tripeptide renin inhibitor (ES-1005).
    Kokubu T; Hiwada K; Murakami E; Muneta S; Morisawa Y; Yabe Y; Koike H; Iijima Y
    J Cardiovasc Pharmacol; 1987; 10 Suppl 7():S88-90. PubMed ID: 2485069
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CP-71,362: a pentapeptide renin inhibitor selective for the canine enzyme.
    Mangiapane ML; MacAndrew JT; Ellery SS; Smith AH; Purcell IM; Kleinman EF; Holt WF; Murphy WR
    Clin Exp Hypertens; 1994 Jul; 16(4):507-33. PubMed ID: 7920458
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design of potent substrate-analogue inhibitors of canine renin.
    Hui KY; Siragy HM; Haber E
    Int J Pept Protein Res; 1992 Aug; 40(2):152-60. PubMed ID: 1446972
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro and in vivo inhibition of human and primate renin by a new potent renin inhibitor: SR 42128.
    De Claviere M; Cazaubon C; Lacour C; Nisato D; Gagnol JP; Evin G; Corvol P
    J Cardiovasc Pharmacol; 1985; 7 Suppl 4():S58-61. PubMed ID: 2412015
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [In vitro and in vivo inhibition of renin by a thiazolylalanyl cyclostatine derivative].
    Muneta S
    Nihon Jinzo Gakkai Shi; 1989 Aug; 31(8):865. PubMed ID: 2512401
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Statine-containing dipeptide and tripeptide inhibitors of human renin.
    Kokubu T; Hiwada K; Nagae A; Murakami E; Morisawa Y; Yabe Y; Koike H; Iijima Y
    Hypertension; 1986 Jun; 8(6 Pt 2):II1-5. PubMed ID: 3087874
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A highly potent and long-acting oral inhibitor of human renin.
    Hiwada K; Kokubu T; Murakami E; Muneta S; Morisawa Y; Yabe Y; Koike H; Iijima Y
    Hypertension; 1988 Jun; 11(6 Pt 2):708-12. PubMed ID: 3134306
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of N-[(S)-1-carboxy-3-phenylpropyl]-L-Ala-L-Pro and its ethyl ester (MK-421) on angiotensin converting enzyme in vitro and angiotensin I pressor responses in vivo.
    Gross DM; Sweet CS; Ulm EH; Backlund EP; Morris AA; Weitz D; Bohn DL; Wenger HC; Vassil TC; Stone CA
    J Pharmacol Exp Ther; 1981 Mar; 216(3):552-7. PubMed ID: 6259322
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New inhibitors of human renin tested in vitro and in vivo in the anaesthetized baboon.
    Tree M; Atrash B; Donovan B; Gamble J; Hallett A; Hughes M; Jones DM; Leckie B; Lever AF; Morton JJ
    J Hypertens; 1983 Dec; 1(4):399-403. PubMed ID: 6398331
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Renin inhibitors: their use in understanding the role of angiotensin II as a pressor hormone.
    Tree M; Szelke M; Leckie B; Atrash B; Donovan B; Hallett A; Jones DM; Lever AF; Morton JJ; Sueiras-Diaz J
    J Cardiovasc Pharmacol; 1985; 7 Suppl 4():S49-52. PubMed ID: 2412013
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Angiotensin-converting enzyme inhibition, anti-hypertensive activity and hemodynamic profile of trandolapril (RU 44570).
    Brown NL; Badel MY; Benzoni F; Zanirato J; Vincent JC; Fichelle J; Worcel M
    Eur J Pharmacol; 1988 Mar; 148(1):79-91. PubMed ID: 3383998
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.